CVS Health Corporation (CVS)
| Market Cap | 97.57B +39.2% |
| Revenue (ttm) | 399.83B +7.9% |
| Net Income | 1.77B -61.7% |
| EPS | 1.39 -62.0% |
| Shares Out | 1.27B |
| PE Ratio | 55.17 |
| Forward PE | 10.70 |
| Dividend | $2.66 (3.47%) |
| Ex-Dividend Date | Jan 22, 2026 |
| Volume | 6,172,214 |
| Open | 77.11 |
| Previous Close | 77.32 |
| Day's Range | 75.72 - 77.50 |
| 52-Week Range | 58.35 - 85.15 |
| Beta | 0.50 |
| Analysts | Strong Buy |
| Price Target | 94.33 (+23.0%) |
| Earnings Date | Feb 10, 2026 |
About CVS
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individu... [Read more]
Financial Performance
In 2025, CVS Health's revenue was $399.83 billion, an increase of 7.87% compared to the previous year's $370.66 billion. Earnings were $1.77 billion, a decrease of -61.68%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for CVS stock is "Strong Buy." The 12-month stock price target is $94.33, which is an increase of 23.00% from the latest price.
News
CVS Health Announces $5 Million Scholarship Program to Support Future Pharmacists in Louisiana
Investment aims to strengthen the pharmacy workforce and expand access to care across the state BATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the launch of a ...
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Saggio Realty Announces Milestone Linked to Sale of Marco Island's CVS-Anchored Plaza
Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza Mike Rivera Of Naples Fl Congratulates Hendricks Comm...
Analysts See Multiple Growth Levers For CVS Health In 2026
CVS Health Corp. (NYSE: CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.
CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026
CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna d...
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript
CVS Health beats expectations as turnaround strategy gains traction
CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahead with a multi-year turnaround. The results underlin...
CVS Profits Hit Nearly $3 Billion As Aetna's Costs Slowly Stabilize
CVS Health Tuesday reported $2.9 billion in fourth quarter net income as the company slowly begins to get a handle on costs that have hit its Aetna health insurance business hard.
CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist.
CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.
CVS Health's turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses
The healthcare giant saw its revenue jump 8% in the fourth quarter
CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector
CVS Health reported earnings that beat analysts' expectations and kept its 2026 profit guidance unchanged, results that may soothe investors spooked by continued turmoil in the health-insurance sector...
CVS Health beats quarterly profit expectations on pharmacy performance
CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription volume at its retail pharmacie...
CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect
CVS Health reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that previously impressed investors. The results signal steady progress in the healt...
CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior year GAAP diluted EPS of $2.30 and Adjusted EPS of $1.09 Full-Year Highlights Total revenues increased t...
Jobs, Consumer Prices, Coca-Cola, CVS, Ford, McDonald's, and More to Watch This Week
The Federal Reserve's dual mandate will be covered this week with the release of the January jobs report and the consumer price index. Plus, earnings from Cisco Systems, Applied Materials, Arista, and...
CVS Pharmacy Now Accepting TrumpRx Discount Cards
WOONSOCKET, R.I., Feb. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its approximately 9,000 community pharmacies are accepting TrumpRx discount cards, which offer savings on ce...
Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey
Press Ganey's inaugural Health Plan of the Year award recognizes Aetna's sustained excellence across member experience, quality performance and provider collaboration. HARTFORD, Conn.
CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists
CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for lower-cost alternatives in some of its preferred drug lists, starting April 1.
CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes - Supporting Affordable Options for Osteoporosis Care
WOONSOCKET, R.I., Feb. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced new steps to further help customers expand adoption of lower-cost biosimilar medications.
Aetna Launches Simplified, Digital-first, Benefits Onboarding Experience for Members in 2026
Delivering a simplified consumer health experience for four million members Integration of first-to-market, enhanced text for select groups with new RCS capabilities to come HARTFORD, Conn., Feb. 5, 2...
CVS Health: Exploit The Sector Panic Ahead Of Earnings
CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth's outlook. CVS's early restructuring, cost cuts, and reduced Medicare expo...
Stock Of The Day: Where Is The Bottom For CVS?
CVS Health Corporation (NYSE: CVS) is flat on Wednesday. The shares dropped by almost 15% yesterday after it was reported that Medicare was proposing rates that are well below expectations.
Is CVS Stock The Best Of The Worst?
CVS stock fell by 14% on January 27 after the CMS revealed a modest 0.09% rate increase for 2027, which was a considerable disappointment compared to investor predictions of 4-6%. Although CVS's 14% d...
Major health insurance stocks sank Tuesday, after Medicare said it was holding payments steady next year
Big health insurers lose nearly $90 billion in market capitalization after Medicare proposed a relatively flat rate increase for next year.